drugset / Trial / NCT06135415

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

NCT06135415

Phase 3 Completed 280 enrolled Almirall, S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 square centimeters (cm\^2) and up to 100 cm\^2 in adult participants with actinic keratosis (AK).

Timeline

Start
2023-12-21
Primary completion
2025-04-30
Completion
2025-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirbanibulin Small molecule 10 unknown Topical

Indications